|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2019
Reichardt, Peter; Schlemmer, Marcus; Delgado Perez, Juan R.; Papai, Zsuzsanna; Prausova, Jana; Melichar, Bohuslav; Fumagalli, Elena; Barone, Carlo; Bauer, Sebastian; Pustowka, Anette; Crippa, Stefania; Castellana, Ramon; Quiering, Claudia und Le Cesne, Axel
(2019):
Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting.
In: Oncology Research and Treatment, Bd. 42, Nr. 12: S. 629-634
2017
Casali, Paolo G.; Zalcberg, John; Cesne, Axel le; Reichardt, Peter; Blay, Jean-Yves; Lindner, Lars H.; Judson, Ian R.; Schoffski, Patrick; Leyvraz, Serge; Italiano, Antoine; Grunwald, Viktor; Pousa, Antonio Lopez; Kotasek, Dusan; Sleijfer, Stefan; Kerst, Jan M.; Rutkowski, Piotr; Fumagalli, Elena; Hogendoorn, Pancras; Litiere, Saskia; Marreaud, Sandrine; Graaf, Winette van der; Gronchi, Alessandro und Verweij, Jaap
(2017):
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
In: Journal of Clinical Oncology, Bd. 35, Nr. 15: S. 1713-1720